University Of Toledo
Toledo, OH Health Science Campus Part of University Of Toledo
- UEI
- M9ACC5DQCNL6
- CAGE
- 59XG6
- Primary NAICS
- 611310 Colleges, Universities, and Professional Schools
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- NAICS codes registered in SAM.gov
- Corporate family
-
-
University Of Toledo
Parent
XA77NAJYELF1
- University Of Toledo M9ACC5DQCNL6
-
University Of Toledo
Parent
XA77NAJYELF1
- SAM.gov registration date
- Physical address
- 3000 Arlington Ave, Toledo, OH 43614, USA
- Website
- utoledo.edu
- Founded
- 1872
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Consumer Discretionary
- Diversified Consumer Services
- Education Services
- Education
- SIC code
- 82 Educational Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About University Of Toledo
University of Toledo Health Science Campus Division acts as a prime recipient of federal grants for biomedical research, with a secondary footprint as a subcontractor and sub-recipient on multi-institutional research initiatives. The division competes exclusively in full-and-open grant awards with no SBA set-asides; it operates as a state-controlled, not-for-profit educational institution within the University of Toledo parent organization, headquartered in Toledo, Ohio.
The division's federal work concentrates almost entirely on NIH-funded basic and translational biomedical research, with a portfolio dominated by Project Grants from the National Cancer Institute (NCI), National Heart Lung and Blood Institute (NHLBI), National Institute on Aging (NIA), and National Institute of Allergy and Infectious Diseases (NIAID). Representative prime grant work spans cancer biology and therapeutic development—including a $418 thousand NCI award on selective allosteric modulators targeting PTH1R signaling for prostate cancer bone metastases (CFDA 93.395), a $636 thousand NCI award on dormancy-mimicking strategies for prostate cancer metastasis inhibition (CFDA 93.396), and a $519 thousand NSF CISE award on clinical adaptive performance enhancement through human-AI teaming to predict medical errors in healthcare settings (CFDA 47.070). The division also holds a $967 thousand Defense Health Agency definitive contract awarded August 2024 for development and delivery of the SAFE-T-NET virtual simulation platform to ensure operational readiness of military health personnel through multimodal assessment and on-demand virtual simulation capabilities, with place of performance in Frederick, Maryland and completion targeted for August 2026.
The division's customer concentration is heavily weighted toward NIH constituent institutes and centers. The top five funding agencies by award count include the National Institutes of Health broadly (64 awards), NCI (24 awards), NHLBI (17 awards), NIA (17 awards), and NIAID (15 awards), accounting for 54% of all awards. The Defense Health Agency represents a distinct secondary customer with nine awards carrying combined potential value of $967 thousand. Research themes span oncology, cardiovascular disease, aging-related disorders, immunology, infectious disease, neurology, and environmental health—with many awards focused on fundamental mechanisms of cancer cell survival, immune dysregulation, and therapeutic resistance in triple-negative breast cancer, prostate cancer, and other malignancies.
The division operates as a prime recipient on 226 of 254 total awards (89%), with sub-award participation on 28 grants (11%). Sub-award work includes collaborative roles on multi-institutional research coordinated through Brown University on interorgan communication in aging-associated cardiac dysfunction, Georgia State University on violence prevention programming, and Cleveland Clinic on kidney transplant outcomes. Recent sub-awardee roles at the division include hosting research coordination, participant recruitment, and biospecimen collection for lung cancer familial studies under Baylor College of Medicine prime and serving as a site investigator on the APOLLO kidney transplant outcomes registry.
The division's activity trajectory shows variability over the past five years—declining from 20 awards in 2022 to 12 in 2023, then recovering to 26 in 2024, followed by 16 in 2025, with only six awards recorded as of mid-2026. The combined obligated dollars across all awards ($336.9 million) substantially exceed the combined potential value ceiling ($1.8 million), reflecting a portfolio where many older or completed awards have already been fully obligated. A recompete cliff of 29 awards carrying combined potential value of $967 thousand completes within the next twenty-four months, representing active grant renewal pressure across the portfolio.
Quick answers
What is University Of Toledo's UEI?
University Of Toledo's Unique Entity ID (UEI) in SAM.gov is M9ACC5DQCNL6.
What is University Of Toledo's CAGE code?
University Of Toledo's CAGE code is 59XG6.
What is University Of Toledo's primary NAICS code?
University Of Toledo's primary NAICS code is 611310 (Colleges, Universities, and Professional Schools).
Where is University Of Toledo located?
University Of Toledo's physical address in SAM.gov is 3000 Arlington Ave, Toledo, OH 43614, USA.
Is University Of Toledo registered in SAM.gov?
Yes. University Of Toledo's SAM.gov registration is active through July 2, 2027.
Who is University Of Toledo's parent company?
University Of Toledo is part of University Of Toledo.
What is University Of Toledo's most recent federal award?
University Of Toledo's most recent federal grant award is Identification of immunoprotective antigens for preventing lyme disease - borrelia burgdorferi (BB) is the causative… (R01AI201788), from National Institute of Allergy and Infectious Diseases, on September 1, 2026.
On GovTribe
See University Of Toledo's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors